Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. More Details
Flawless balance sheet with weak fundamentals.
Share Price & News
How has Polarean Imaging's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PLLW.F has not had significant price volatility in the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: Insufficient data to determine how PLLW.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how PLLW.F performed against the US Market.
Price Volatility Vs. Market
How volatile is Polarean Imaging's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Polarean Imaging undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate PLLW.F's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate PLLW.F's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: PLLW.F is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: PLLW.F is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate PLLW.F's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: PLLW.F is overvalued based on its PB Ratio (13.8x) compared to the US Medical Equipment industry average (3.7x).
How is Polarean Imaging forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Polarean Imaging has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine Polarean Imaging's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Polarean Imaging's filings and announcementshere.
- Explore growth companies in the Healthcare industry.
How has Polarean Imaging performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PLLW.F is currently unprofitable.
Growing Profit Margin: PLLW.F is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: PLLW.F is unprofitable, and losses have increased over the past 5 years at a rate of 33% per year.
Accelerating Growth: Unable to compare PLLW.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PLLW.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.2%).
Return on Equity
High ROE: PLLW.F has a negative Return on Equity (-132.97%), as it is currently unprofitable.
How is Polarean Imaging's financial position?
Financial Position Analysis
Short Term Liabilities: PLLW.F's short term assets ($3.2M) exceed its short term liabilities ($1.9M).
Long Term Liabilities: PLLW.F's short term assets ($3.2M) exceed its long term liabilities ($559.3K).
Debt to Equity History and Analysis
Debt Level: PLLW.F is debt free.
Reducing Debt: PLLW.F currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PLLW.F has sufficient cash runway for 5 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: PLLW.F is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.
What is Polarean Imaging current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate PLLW.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PLLW.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PLLW.F's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PLLW.F's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of PLLW.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Clairis Hullihen (67 yo)
Mr. Clairis Richard Hullihen serves as the Chief Executive Officer of Polarean Imaging Plc and has been its Director since May 30, 2017. Mr. Hullihen has many years in medical imaging experience. He began ...
CEO Compensation Analysis
Compensation vs Market: Clairis's total compensation ($USD322.64K) is below average for companies of similar size in the US market ($USD601.89K).
Compensation vs Earnings: Clairis's compensation has increased whilst the company is unprofitable.
|CEO & Director||no data||US$322.64k||1.81% |
|COO & Director||3.33yrs||US$211.88k||0.29% |
|Non-Executive Director||0.25yr||no data||0.22% |
|Independent Chairman||0.58yr||US$54.04k||1.5% |
|Non-Executive Director||3.33yrs||US$64.04k||no data|
Experienced Board: PLLW.F's board of directors are considered experienced (3.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 59.5%.
Polarean Imaging plc's company bio, employee growth, exchange listings and data sources
- Name: Polarean Imaging plc
- Ticker: PLLW.F
- Exchange: OTCPK
- Founded: 2016
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: UK£70.396m
- Listing Market Cap: UK£89.663m
- Shares outstanding: 161.83m
- Website: https://www.polarean.com
Number of Employees
- Polarean Imaging plc
- 2500 Meridian Parkway
- Suite 175
- North Carolina
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|POLX||AIM (London Stock Exchange AIM Market)||Yes||Ordinary Shares||GB||GBP||Mar 2018|
|PLLW.F||OTCPK (Pink Sheets LLC)||Yes||Ordinary Shares||US||USD||Mar 2018|
Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. The company engages in the development and commercial ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/23 06:22|
|End of Day Share Price||2020/07/01 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.